[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339011-105":59,"doc-detail-339011-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeting-carnitine-palmitoyl-transferase-1a-cpt1a-induces-ferroptosis-and-synergizes-with-immunotherapy-in-lung-cancer","Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer","","Despite immune checkpoint therapy, lung cancer often shows no response or recurrence driven by drug resistance. Cancer stem cells (CSCs) contribute to resistance and immune evasion, but how CSCs defend against ferroptosis during tumor immune escape remains unclear. This study integrates metabolomics, transcriptomics, a lung epithelial Cpt1a-knockout mouse model, and clinical analysis to show CPT1A promotes ferroptosis resistance and CD8+ T-cell inactivation via a CPT1A/c-Myc feedback loop and NRF2/GPX4–ACSL4 regulation. Targeting CPT1A enhances checkpoint blockade–induced anti-tumor immunity and tumoral ferroptosis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-carnitine-palmitoyl-transferase-1a-cpt1a-induces-ferroptosis-and-synergizes-with-immunotherapy-in-lung-cancer/339011/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-carnitine-palmitoyl-transferase-1a-cpt1a-induces-ferroptosis-and-synergizes-with-immunotherapy-in-lung-cancer/339011.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is immunotherapy response limited in lung cancer?","Question",{"text":113,"@type":114},"Despite immune checkpoint therapy, many patients show no response or experience recurrence. Cancer stem cells are central drivers of resistance and immune evasion in lung cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does CPT1A play in ferroptosis and CSC survival?",{"text":118,"@type":114},"CPT1A, a key rate-limiting enzyme of fatty acid oxidation, promotes ferroptosis resistance in cancer stem cells. It does so through a mechanistic CPT1A/c-Myc feedback loop that strengthens antioxidant capacity and suppresses ferroptosis.",{"name":120,"@type":111,"acceptedAnswer":121},"How does targeting CPT1A affect immunotherapy efficacy?",{"text":122,"@type":114},"Targeting CPT1A enhances immune checkpoint blockade–induced anti-tumor immunity. It also increases tumoral ferroptosis in tumor-bearing mice.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339011,1790184156,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nTargeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer  \nLei Ma1,2, Chong Chen 1,2 ✉ , Chunxing Zhao1,2, Tong Li3,4, Lingyu Ma 1,2, Jiayu Jiang1,2, Zhaojun Duan1,2, Qin Si1,2, Tsung-Hsien Chuang4, Rong Xiang 5 and Yunping Luo1,2 ✉  \n\n| | Despite the successful application of immune checkpoint therapy, no response or recurrence is typical in lung cancer. Cancer stem cells (CSCs) have been identiﬁed as a crucial player in immunotherapy-related resistance. Ferroptosis, a form of cell death driven by iron-dependent lipid peroxidation, is highly regulated by cellular metabolism remolding and has been shown to have synergistic effects when combined with immunotherapy. Metabolic adaption of CSCs drives tumor resistance, yet the mechanisms of their ferroptosis defense in tumor immune evasion remain elusive. Here, through metabolomics, transcriptomics, a lung epithelialspeciﬁc Cpt1a-knockout mouse model, and clinical analysis, we demonstrate that CPT1A, a key rate-limiting enzyme of fatty acid oxidation, acts with L-carnitine, derived from tumor-associated macrophages to drive ferroptosis-resistance and CD8+ T cells inactivation in lung cancer. Mechanistically, CPT1A restrains ubiquitination and degradation of c-Myc, while c-Myc transcriptionally activates CPT1A expression. The CPT1A/c-Myc positive feedback loop further enhances the cellular antioxidant capacity by activating the NRF2/GPX4 system and reduces the amount of phospholipid polyunsaturated fatty acids through ACSL4 downregulating, thereby suppressing ferroptosis in CSCs. Signiﬁcantly, targeting CPT1A enhances immune checkpoint blockadeinduced anti-tumor immunity and tumoral ferroptosis in tumor-bearing mice. The results illustrate the potential of a mechanismguided therapeutic strategy by targeting a metabolic vulnerability in the ferroptosis of CSCs to improve the efﬁcacy of lung cancer | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  | |\n|  |  |  |\n| | immunotherapy. | |\n|  | Signal Transduction and Targeted Therapy (2024)9:64 ; [https://doi.org/10.1038/s41392-024-01772-w](https://doi.org/10.1038/s41392-024-01772-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nLung cancer is the leading cause of cancer-related deaths, with non-small cell lung cancer (NSCLC) accounting for 80% of cases.1 Despite the availability of molecular targeted therapies and immunotherapy for patients with lung cancer, recurrence and disease progression due to drug resistance are common.2 Cancer stem cells (CSCs), which are pivotal drivers of tumor initiation, resistance, and metastasis, play a critical role in tumor immune evasion and immunotherapy tolerance.3–5 CSCs possess the potential for self-renewal and differentiation, which fuels and sustains tumor growth at low cell numbers, and they must ﬁrst overcome the formidable barrier of immune surveillance. It is speculated that some CSCs evade detection and eradication by immune cells to escape antitumor immunity; however, the speciﬁc mechanisms behind this phenomenon remain largely unknown. Ferroptosis, a type of cell death driven by iron-dependent lipid peroxidation, has been implicated in various biological processes including development, aging, immunity, and cancer.6,7 The convergence of three signiﬁcant areas of research—metabolism, reactive oxygen species (ROS) biology, and iron regulation—has laid the groundwork for understanding ferroptosis.6 Recent ﬁndings have shed light on the metabolic plasticity of CSCs and have provided intriguing insights into how metabolic rewiring  \nplays a crucial role in CSCs’ resistance to ferroptosis.8,9 In certain instances, this metabolic reprogramming has been associated with an acquired sensiti","cbCaiu7xNAqrXEwC","https://ap.wps.com/l/cbCaiu7xNAqrXEwC","pdf",7461509,15,"English","# Introduction\n## Lung cancer immune resistance and cancer stem cells\n## Ferroptosis as immunogenic cell death\n## Fatty acid oxidation and CPT1A in ferroptosis regulation","[{\"question\":\"Why is immunotherapy response limited in lung cancer?\",\"answer\":\"Despite immune checkpoint therapy, many patients show no response or experience recurrence. Cancer stem cells are central drivers of resistance and immune evasion in lung cancer.\"},{\"question\":\"What role does CPT1A play in ferroptosis and CSC survival?\",\"answer\":\"CPT1A, a key rate-limiting enzyme of fatty acid oxidation, promotes ferroptosis resistance in cancer stem cells. It does so through a mechanistic CPT1A/c-Myc feedback loop that strengthens antioxidant capacity and suppresses ferroptosis.\"},{\"question\":\"How does targeting CPT1A affect immunotherapy efficacy?\",\"answer\":\"Targeting CPT1A enhances immune checkpoint blockade–induced anti-tumor immunity. It also increases tumoral ferroptosis in tumor-bearing mice.\"}]","Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer | PDF",1790027275,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfc083168a55647e89b854ae67969d5f.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/367151f7384c7cfd179d55bf11b3ec9f.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ced8372be1309a0d39ebace89dcf16b.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a05ec238b6225748b2eb1a360034abb.webp",980,1301]